Guangdong Biolight Meditech Co., Ltd. (300246.SZ)
CNY 7.6
(-0.78%)
CNY 7.6
(-0.78%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 86.27 Million CNY | 1011.52% |
| 2022 | -9.46 Million CNY | -150.61% |
| 2021 | 18.7 Million CNY | 109.83% |
| 2020 | -190.34 Million CNY | -8540.23% |
| 2019 | -2.2 Million CNY | 97.17% |
| 2018 | -77.83 Million CNY | 38.26% |
| 2017 | -126.05 Million CNY | 29.66% |
| 2016 | -179.2 Million CNY | 20.38% |
| 2015 | -225.07 Million CNY | -2.31% |
| 2014 | -219.99 Million CNY | 7.75% |
| 2013 | -238.47 Million CNY | 21.23% |
| 2012 | -302.73 Million CNY | 1.36% |
| 2011 | -306.91 Million CNY | -548.09% |
| 2010 | -47.35 Million CNY | -54.41% |
| 2009 | -30.67 Million CNY | -228.38% |
| 2008 | -9.33 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 166.16 Million CNY | 12.01% |
| 2024 Q3 | 149.02 Million CNY | 5.54% |
| 2024 Q1 | 148.35 Million CNY | 71.96% |
| 2023 Q3 | 99.11 Million CNY | -11.34% |
| 2023 FY | 86.27 Million CNY | 1011.52% |
| 2023 Q2 | 111.79 Million CNY | 12.26% |
| 2023 Q4 | 86.27 Million CNY | -12.96% |
| 2023 Q1 | 99.58 Million CNY | 1152.21% |
| 2022 Q3 | -344.19 Million CNY | 21.66% |
| 2022 Q2 | -439.38 Million CNY | 4.64% |
| 2022 Q1 | -460.75 Million CNY | -2563.51% |
| 2022 FY | -9.46 Million CNY | -150.61% |
| 2022 Q4 | -9.46 Million CNY | 97.25% |
| 2021 Q1 | -186.37 Million CNY | 2.09% |
| 2021 FY | 18.7 Million CNY | 109.83% |
| 2021 Q4 | 18.7 Million CNY | 151.15% |
| 2021 Q3 | -36.56 Million CNY | 72.86% |
| 2021 Q2 | -134.74 Million CNY | 27.7% |
| 2020 Q1 | -47.48 Million CNY | -2055.45% |
| 2020 Q3 | -286.98 Million CNY | -6.12% |
| 2020 Q4 | -190.34 Million CNY | 33.67% |
| 2020 FY | -190.34 Million CNY | -8540.23% |
| 2020 Q2 | -270.43 Million CNY | -469.5% |
| 2019 Q1 | -62.72 Million CNY | 19.41% |
| 2019 FY | -2.2 Million CNY | 97.17% |
| 2019 Q4 | -2.2 Million CNY | 94.25% |
| 2019 Q3 | -38.32 Million CNY | 9.9% |
| 2019 Q2 | -42.54 Million CNY | 32.17% |
| 2018 Q3 | -38.93 Million CNY | 54.07% |
| 2018 Q4 | -77.83 Million CNY | -99.92% |
| 2018 Q2 | -84.76 Million CNY | -10.53% |
| 2018 FY | -77.83 Million CNY | 38.26% |
| 2018 Q1 | -76.68 Million CNY | 39.16% |
| 2017 Q4 | -126.05 Million CNY | -21.9% |
| 2017 Q3 | -103.4 Million CNY | 0.25% |
| 2017 Q2 | -103.67 Million CNY | 18.29% |
| 2017 Q1 | -126.88 Million CNY | 29.2% |
| 2017 FY | -126.05 Million CNY | 29.66% |
| 2016 Q1 | -204.57 Million CNY | 9.11% |
| 2016 FY | -179.2 Million CNY | 20.38% |
| 2016 Q4 | -179.2 Million CNY | -16.64% |
| 2016 Q3 | -153.64 Million CNY | 18.49% |
| 2016 Q2 | -188.49 Million CNY | 7.86% |
| 2015 Q3 | -192.6 Million CNY | 6.34% |
| 2015 Q2 | -205.64 Million CNY | 0.38% |
| 2015 Q1 | -206.42 Million CNY | 6.17% |
| 2015 FY | -225.07 Million CNY | -2.31% |
| 2015 Q4 | -225.07 Million CNY | -16.86% |
| 2014 Q1 | -237.6 Million CNY | 0.36% |
| 2014 Q2 | -226.93 Million CNY | 4.49% |
| 2014 FY | -219.99 Million CNY | 7.75% |
| 2014 Q4 | -219.99 Million CNY | -5.14% |
| 2014 Q3 | -209.23 Million CNY | 7.8% |
| 2013 Q4 | -238.47 Million CNY | -1.06% |
| 2013 FY | -238.47 Million CNY | 21.23% |
| 2013 Q3 | -235.97 Million CNY | 19.55% |
| 2013 Q2 | -293.31 Million CNY | 2.02% |
| 2013 Q1 | -299.36 Million CNY | 1.11% |
| 2012 Q1 | -308.15 Million CNY | -0.4% |
| 2012 Q3 | -288.77 Million CNY | -1.21% |
| 2012 Q4 | -302.73 Million CNY | -4.83% |
| 2012 FY | -302.73 Million CNY | 1.36% |
| 2012 Q2 | -285.32 Million CNY | 7.41% |
| 2011 Q3 | -291.02 Million CNY | -412.9% |
| 2011 Q2 | -56.74 Million CNY | 0.0% |
| 2011 FY | -306.91 Million CNY | -548.09% |
| 2011 Q4 | -306.91 Million CNY | -5.46% |
| 2010 FY | -47.35 Million CNY | -54.41% |
| 2010 Q4 | -47.35 Million CNY | 0.0% |
| 2009 FY | -30.67 Million CNY | -228.38% |
| 2008 FY | -9.33 Million CNY | 0.0% |